In our first update of the Decentralised Clinical Trials (DCT) Adoption Tracker for 2022, we saw three notable trends on telemedicine, use of DCT among institutions and non-profit organisations, as well as among small and medium-sized CROs. The DCT Adoption Tracker analyses 12 years of data based on clinical registry protocols, research papers, and press releases to find trends on the uptake of decentralisation approaches.  

Data from the first three months of 2022 shows telemedicine use in clinical trials is set to continue gaining momentum. To date, 70% of trials involving decentralisation have included telemedicine in 2022, compared to less than half in 2019. 

There is also the continued rise of institutions and non-profit organisations utilising decentralisation. Between January and March this year, 10% of new trials involving institutions or non-profits in high-income countries used decentralised trial elements, compared to 5% in 2019. In contrast, just 7% of trials with commercial sponsors have included decentralisation so far this year. 

Last year saw a dramatic increase in the use of decentralisation by small and medium-sized CROs, a trend which has continued in the first three months of 2022. Since the beginning of 2021, 13% of trials involving small or medium-sized CROs have used decentralisation. This is in comparison to just 8% of trials featuring large CROs, including only seven trials so far in 2022. 

Revisit or discover our DCT Adoption Tracker with Q1 updates here. Our tracker pinpoints what type of sponsors are leading DCT adopters, as well as which decentralisation approaches are most used. We analyse DCT data across different countries and different indications. We aim to update the tracker periodically to keep you abreast on DCT trends. You can sign up to our newsletter so you won't miss the latest.   

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.